|
|
|
|
These laboratory-confirmed cases of botulism demonstrate that clinical use of unlicensed botulinum toxin A can result in severe, life-threatening illness. Further education and regulation are needed to prevent the inappropriate marketing, safe, and clinical use of unlicensed botulinum toxin products. |
|